INHIBITORY EFFECT OF EPINEPHRINE AND NOREPINEPHRINE ON CARRAGEENIN-INDUCED PLANTAR EDEMA IN THE RAT

I. Frydas^1*

¹Aristotelian University, Thessaloniki, Greece

*Correspondence to:
Ilias Frydas, MD
Laboratory of Microbiology and Infectious Diseases,
School of Veterinary Medicine,
Aristotle University of Thessaloniki,
Greece
e-mail: frydas@vet.auth.gr

Received: 23 January 2019 Accepted: 11 March 2019

2279-5855 (2019) Copyright © by BIOLIFE This publication and/or article is for individual use only and may not be further reproduced without written permission from the copyright holder. Unauthorized reproduction may result in financial and other penalties Disclosure: all authors report no conflicts of interest relevant to this article.

Keywords: carrageenin, epinephrine, norepinephrine, edema, inflammation, catecholamines

In this short paper we report that carrageenin-induced plantar edema in the rat paw is inhibited by epinephrine or norepinephrine. When these catecholamines are administered in combination with carrageenin, they inhibit the inflammatory response in the following three hours, at which point the effects gradually subside.

Inflammation is a typical immune mechanism, which is established in the presence of chemical, physical, or biological pathogens with tissue and vascular damage, but also some self-type of immune reactions can cause inflammation and cell death (1). Irritating foreign substances injected into tissue can cause inflammation and edema (2). Carrageenin is a complex molecule extracted from red algae (Chondrus crispus and Gigartina stellata) which contains two polysaccharides (3). When carrageenin is injected into the plantar rat paw, it causes an increase in the levels of fatty acids, including hydroxyeicosatetraenoic acid (5-HETE), which mediates inflammation (4). Tissue edema is a clinical manifestation with abnormal accumulation of lymphatic fluid at the inflamed site, characterized by swelling, reduced function, and often pain (5).

 Catecholamines are water-soluble chemical compounds (hormones) released by the adrenal glands under conditions of stress, that circulate in the blood bound to plasma proteins (6). The most well-studied catecholamines are epinephrine (adrenaline) and norepinephrine (noradrenaline) which derive from dopamine, which in turn derives from tyrosine (7) (Fig. 1).

Epinephrine and norepinephrine, secreted by the adrenal gland and local sympathetic neurons, regulate the immune system by activating the β2-adrenergic receptor on immune cells, producing cell migration and cytokine secretion (Adrenergic regulation of immune cell function and inflammation (8). The aim of this study is to investigate whether these two catecholamines inhibit carrageenin-induced inflammation.

In this study, carrageenin is injected alone intraplantar and in combination with the epinephrine or norepinephrine in order to inhibit plantar edema (9). Male Wistar rats (100-180 g) were used and anti-edematous activity of epinephrine and norepinephrine by simultaneous injection with carrageenin was investigated and after 3 h the edema was measured. Paw edema was induced by intraplantar injection of 0.1 ml of 1% solution of carrageenin. The volume was measured in nanogram of the rat paw.

Using this experimental model, we report the inhibitory action of epinephrine and norepinephrine on carrageenin-induced plantar edema in rats. The inhibitory action of these two catecholamines is short-lived, starting immediately after injection and reaching the plateau at 3 h after treatment, an effect that gradually decreased. The efficacy of epinephrine and norepinephrine is high except for dopamine, for which higher doses are needed (data not shown). The inhibitory effect of norepinephrine was slightly less pronounced than that of epinephrine.

The results obtained demonstrate that carrageenin causes a strong inflammatory effect (Table I) correlating to the amount of edema on the sole of the rat’s foot (10). When epinephrine and norepinephrine are administered with carrageenin, the inflammatory effect is strongly inhibited. This inhibition appeared only for a short period of time (3 h) and then gradually decreased over time.

DISCUSSION

Epinephrine and norepinephrine are endogenous anti-inflammatory catecholamines which are released after an inflammatory process as a defensive response of the body to try to restore the physiological tissue state (11).

In this short article, the powerful inflammatory effect of carrageenin is confirmed, and we demonstrate that when this proinflammatory compound is administered in combination with epinephrine or norepinephrine, inflammation is inhibited in the first phase of induction, an effect that diminishes over time until it disappears (12). In addition, in our experiments, epinephrine and norepinephrine were increased in the urine of the rats treated with carrageenin induced edema, an effect that may be species specific and thus not detectable in humans (13). It has been reported that in humans, inflammatory stimuli such as ultraviolet radiation causes a decrease in epinephrine or norepinephrine (Nicotinic acetylcholine receptors in glucose homeostasis: the acute hyperglycemic and chronic insulin-sensitive effects of nicotine suggest dual opposing roles of the receptors in male mice (14, 15).

In conclusion, epinephrine or norepinephrine can inhibit the edematous inflammatory response of carrageenin in the first 3 hours after the combined treatment, followed by a gradual decrease in inhibition until it disappears (16).

 Conflict of interest

The author declares that they have no conflict of interest.

 REFERENCES

1. Rock KL, Kono H. The Inflammatory Response to Cell Death. Annual Review of Pathology: Mechanisms of Disease. 2008;3(1):99-126. doi:https://doi.org/10.1146/annurev.pathmechdis.3.121806.151456
2. Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann-Klein M, Zimmermann U, Duffy DM. Foreign Body Granulomas after All Injectable Dermal Fillers: Part 1. Possible Causes. Plastic and Reconstructive Surgery. 2009;123(6):1842-1863. doi:https://doi.org/10.1097/prs.0b013e31818236d7
3. THERKELSEN GH. CARRAGEENAN. Industrial Gums. Published online 1993:145-180. doi:https://doi.org/10.1016/b978-0-08-092654-4.50011-5
4. Sisignano M, Angioni C, Ferreiros N, et al. Synthesis of Lipid Mediators during UVB-Induced Inflammatory Hyperalgesia in Rats and Mice. Romanovsky AA, ed. PLoS ONE. 2013;8(12):e81228. doi:https://doi.org/10.1371/journal.pone.0081228
5. Radhakrishnan K, Rockson SG. The Clinical Spectrum of Lymphatic Disease. Annals of the New York Academy of Sciences. 2008;1131(1):155-184. doi:https://doi.org/10.1196/annals.1413.015
6. Chalkias A. Post-cardiac arrest syndrome: Mechanisms and evaluation of adrenal insufficiency. World Journal of Critical Care Medicine. 2012;1(1):4. doi:https://doi.org/10.5492/wjccm.v1.i1.4
7. Barnes MA, Carson MJ, Nair MG. Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system. Cytokine. 2015;72(2):210-219. doi:https://doi.org/10.1016/j.cyto.2015.01.008
8. Scanzano A, Cosentino M. Adrenergic regulation of innate immunity: a review. Frontiers in Pharmacology. 2015;6. doi:https://doi.org/10.3389/fphar.2015.00171
9. Horváth G, Kékesi G, Dobos I, Szikszay M, Klimscha W, Benedek G. Effect of intrathecal agmatine on inflammation-induced thermal hyperalgesia in rats. European Journal of Pharmacology. 1999;368(2-3):197-204. doi:https://doi.org/10.1016/s0014-2999(99)00060-6
10. Gilligan JP, Lovato SJ, Erion MD, Jeng AY. Modulation of carrageenan-induced hind paw edema by substance P. Inflammation. 1994;18(3):285-292. doi:https://doi.org/10.1007/bf01534269
11. Green KL. Role of endogenous catecholamines in the anti-inflammatory activity of α-adrenoceptor blocking agents. British Journal of Pharmacology. 1974;51(1):45-53. doi:https://doi.org/10.1111/j.1476-5381.1974.tb09630.x
12. Deumens R, Steyaert A, Forget P, et al. Prevention of chronic postoperative pain: Cellular, molecular, and clinical insights for mechanism-based treatment approaches. Progress in Neurobiology. 2013;104:1-37. doi:https://doi.org/10.1016/j.pneurobio.2013.01.002
13. Brimijoin S, Hammond P, Khraibi AA, Tyce GM. Catecholamine Release and Excretion in Rats with Immunologically Induced Preganglionic Sympathectomy. Journal of Neurochemistry. 2008;62(6):2195-2204. doi:https://doi.org/10.1046/j.1471-4159.1994.62062195.x
14. Vu CU, Siddiqui JA, Wadensweiler P, et al. Nicotinic Acetylcholine Receptors in Glucose Homeostasis: The Acute Hyperglycemic and Chronic Insulin-Sensitive Effects of Nicotine Suggest Dual Opposing Roles of the Receptors in Male Mice. Endocrinology. 2014;155(10):3793-3805. doi:https://doi.org/10.1210/en.2014-1320
15. Sinha-Hikim AP, Sinha-Hikim I, Friedman TC. Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights. Frontiers in Endocrinology. 2017;8. doi:https://doi.org/10.3389/fendo.2017.00023